ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

CECILIO HERNANDEZ LATORRE MD

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,920Medicare Part D Prescriptions Filled, Including Refills

Rank: 180 out of 1479

$314K Total Retail Price of All Prescriptions

Rank: 154 out of 1479

365 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
1% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 365 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

6% of this provider’s 365 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

4% of this provider’s 8,354 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$35 was the average price of a prescription from this provider, compared to $33 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SIMVASTATIN 492 475 1 1
SERTRALINE HCL 381 366 2 38
METFORMIN HCL 300 281 3 2
ENALAPRIL MALEATE 286 235 4 3
LEVOTHYROXINE SODIUM 268 249 5 9
DONEPEZIL HCL 238 224 6 45
AMLODIPINE BESYLATE 233 223 7 6
OMEPRAZOLE 222 213 8 7
LOSARTAN POTASSIUM 208 196 9 8
MEGESTROL ACETATE 208 197 R 9 109
NAMENDA 179 169 11 69
FUROSEMIDE 157 152 12 15
CLOTRIMAZOLE-BETAMETHASONE 157 154 12 39
RISPERIDONE 155 155 14 88
RANITIDINE HCL 150 147 15 4
TRAMADOL HCL-ACETAMINOPHEN 133 128 16 18
ATENOLOL 129 115 17 11
METOPROLOL TARTRATE 129 127 17 17
HYDROCHLOROTHIAZIDE 128 125 19 10
ISOSORBIDE MONONITRATE ER 114 114 20 31
DICLOFENAC SODIUM 105 91 21 68
GABAPENTIN 104 90 22 5
PANTOPRAZOLE SODIUM 103 99 23 48
CIPROFLOXACIN HCL 103 89 23 26
TRAZODONE HCL 98 95 25 122
LISINOPRIL 97 97 26 16
GLIPIZIDE 91 80 27 13
QUETIAPINE FUMARATE 88 78 28 108
DIGOXIN 87 87 29 61
METOCLOPRAMIDE HCL 87 85 29 127
CLOPIDOGREL 85 83 31 46
AVELOX 83 74 32 168
CEFADROXIL 74 70 33 117
LOSARTAN-HYDROCHLOROTHIAZIDE 72 71 34 14
PENTOXIFYLLINE 70 66 35 40
PLAVIX 67 62 36 52
TAMSULOSIN HCL 63 49 37 36
HYDROCODONE-ACETAMINOPHEN 56 42 S3 38 163
MECLIZINE HCL 55 51 39 50
METOPROLOL SUCCINATE 54 54 40 51
SYNTHROID 53 51 41 12
GEMFIBROZIL 53 53 41 49
PREDNISONE 53 51 41 67
CARVEDILOL 52 52 44 32
NEOMYCIN-POLYMYXIN-DEXAMETH 51 50 45 234
GLIMEPIRIDE 51 51 45 21
PHENYTOIN SODIUM EXTENDED 50 38 47 132
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.